The CNODES network of researchers, trainees, and analysts conduct studies using administrative healthcare data in response to queries from Canadian regulators. The results of these studies are published in open-access academic journals. CNODES also publishes a selection of its methodological advances, knowledge translation initiatives, and trainee projects.

Mehrabadi A, Reynier P, Platt RW, Filion KB. Domperidone for insufficient lactation in England 2002-2015: a drug utilization study with interrupted time series analysis. Pharmacoepidemiol Drug Saf 2018 Dec;27(12):1316-1324.

Ayele HT, Dormuth CR, Filion KB. Long-term use of proton pump inhibitors and community-acquired pneumonia: adverse effect or bias?. JAGS. 2018 Dec;66(12):2427-2428.

Montastruc F, Loo S, Renoux C. Trends in first gabapentin and pregabalin prescriptions in primary care in the United Kingdom, 1993-2017. JAMA. 2018 Nov 27;320(20):2149-2151.

Langan SM, Schmidt SAJ, Wing K, Ehrenstein V, Nicholls SG, Filion KB, Klungel O, Petersen I,  Sorensen HT, Dixon WG, Guttmann A, Harron K, Hemkens LG, Moher D, Schneeweiss S, Smeeth L, Sturkenboom M, von Elm E,  Wang SV, Benchimol EI. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement for Pharmacoepidemiology (RECORD-PE). BMJ 2018 Nov 14;363:k3532.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L. Glucagon-like peptide-1 analogues and the risk of diabetic retinopathy. Diabetes Care. 2018 Nov;41(11):2330-2338.

Douros A, Abrahami D, Yin H, Yu OHY, Renoux C, Hudson M, Azoulay L. Use of dipeptidyl peptidase-4 inhibitors and new-onset rheumatoid arthritis in patients with type 2 diabetes. Epidemiology 2018 Nov;29(6):904-912.

Hicks BM, Filion KB, Yin H, Sakr L, Udell JA, Azoulay L.  Angiotensin converting enzyme inhibitors and the risk of lung cancer: population based cohort study.  BMJ 2018 Oct 24;363:k4209.

Sinyavskaya L, Matteau A, Johnson S, Durand M. Methodological challenges in assessment of current use of warfarin among patients with atrial fibrillation using dispensation data from administrative healthcare database. Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):979-986.

Douros A, Dell’Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S. Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study. BMJ. 2018 Jul 18;362:k2693

Karim ME, Petkau J, Gustafson P, Platt RW, Tremlett H; BeAMS Study Group. Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies. Stat Methods Med Res. 2018 Jun;27(6):1709-1722.